AGENDA - Main Workshop DAY 2A
June 19, 2020, 11am to 4pm ET

DAY 2A - Multiple Technologies: June 19, 2020 (EDT time listed)

11:00am-11:10am: Dr. Hendrik Neubert, Sr. Director Translational Biomeasures and Protein Biomarkers Group, Pfizer
"Introduction - Application of Multiple Technologies to solve Complex Bioanalytical Issues"

Application of Multiple Technologies to solve Complex Bioanalytical Issues

Chair: Dr. Hendrik Neubert, Sr. Director Translational Biomeasures and Protein Biomarkers Group, Pfizer
11:10am-11:25am: Dr. Kay-Gunnar Stubenrauch, Head Large Molecule Bioanalytical Sciences, Roche
"Biotin Interference in LBA – Potential Bias and Challenges with Bridging ADA Assays"
11:25am-11:40am: Mr. William Mylott, Director Biologics by LCMS/MS, PPD
"Endogenous Biotin Interference for Hybrid LBA/LCMS: Potential Bias and Challenges in Quantitation of Biotherapeutics and Biomarkers"
11:40am-12:00pm: Dr. Hendrik Neubert, Sr. Director Translational Biomeasures and Protein Biomarkers Group, Pfizer
"Adeno-Associated Virus Gene Therapy: Transgene and Protein Analysis by PCR and LCMS"
12:00pm-12:20pm: Dr. Boris Gorovits, Sr. Director Bioanalytical Lab, Pfizer
"Current Experience in ADA Isotype Analysis Using LBA (MSD), Hybrid LBA/LCMS and Genalyte Technologies: Application of multiple technologies to solve complex bioanalytical issues in Immunogenicity OR Can we isotype ADA response and Why"
12:20pm-12:40pm: Dr. Mark Qian, Director Bioanalytical Sciences, Takeda
"Novel Cases of Immunocapture-LC/MS and LBA Complementary & Orthogonal Applications for PK & ADA Assays"
12:40pm-01:10pm: Dr. Kay-Gunnar Stubenrauch, Head Large Molecule Bioanalytical Sciences, Roche
Mr. William Mylott, Director Biologics by LCMS/MS, PPD
Dr. Hendrik Neubert, Sr. Director Translational Biomeasures and Protein Biomarkers Group, Pfizer
Dr. Boris Gorovits, Sr. Director Bioanalytical Lab, Pfizer
Dr. Mark Qian, Director Bioanalytical Sciences, Takeda
"Panel Discussion on Panel Biotin Interference, qPCR, LBA, Hybrid LBA/LCMS "
01:10pm-01:40pm: Social Networking - Time to "Visit" Exhibitors and Posters
01:40pm-01:55pm: Dr. Lindsay King, Assoc. Research Fellow BioMedicines Design, Pfizer
"Introduction to Extracellular Vesicles and Measurement by Flow Cytometry"
01:55pm-02:10pm: Dr. Hendrik Neubert, Sr. Director Translational Biomeasures and Protein Biomarkers Group, Pfizer
"Protein Biomarker Mass Spectrometry from Extracellular Vesicles"
02:10pm-02:25pm: Dr. Jean-Claude Marshall, Sr. Director Clinical Biomarker Group and Precision Medicine, Pfizer
"Extracellular Vesicles for Early Clinical Biomarkers by qPCR and Western Blots"
02:25pm-02:55pm: Dr. Lindsay King, Assoc. Research Fellow BioMedicines Design, Pfizer
Dr. Hendrik Neubert, Sr. Director Translational Biomeasures and Protein Biomarkers Group, Pfizer
Dr. Jean-Claude Marshall, Sr. Director Clinical Biomarker Group and Precision Medicine, Pfizer
"Panel Discussion on Exosomes Bioanalysis"
02:55pm-03:10pm: 14th WRIB AWARDS Presentation - Outstanding Contribution Awards and Best Poster Awards
03:10pm-03:40pm: Social Networking - Time to "Visit" Exhibitors and Posters




Final Agenda Agenda at a Glance